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CDiagnosis of intravascular catheter infection
Philippe EggimannPurpose of review
To review the distinction between catheter-related and
catheter-associated infections and to report the recent
advances in the methods used for their diagnosis.
Recent findings
The distinction between device-associated and device-
related infections affects the effective benchmarking of the
rates of both types of infection. Numerous microbiological
methods have been described to diagnose these infections.
Studies comparing the performance of microbiological
methods that avoid the removal of the intravascular device
have recently suggested that they may be effective in daily
life.
Summary
The present review summarizes recent advances in the
methods currently available to diagnose intravascular
catheter-related infections and their performance at the
bedside.
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Infections associated with the use of intravascular
catheters or devices represent 10–20% of all nosocomial
infections. They may complicate the stay of up to 10% of
intensive care unit (ICU) patients. Almost all patients
staying in an ICU require at least one intravascular device
for fluid/drug administration, and approximately half are
central venous catheters (CVCs) [1]. According to data
from the National Nosocomial Infections Surveillance
system, it is estimated that at least 48 600 ICU patients
develop a CVC-related bloodstream infection every
year in US ICUs (approximately five episodes per
1000 catheter-days). These infections, mostly caused
by coagulase-negative staphylococci, Staphylococcus
aureus, Enterococcus species, and Candida species, are
associated with considerable morbidity (prolonged
length of stay and increased costs) and mortality [2].
Although debated by experts with regard to magnitude,
the attributable mortality of these infections may
correspond to 5000–15 000 deaths directly caused by
catheter-related infections; the benchmarking of rates is
currently included in the assessment of quality of care in
many institutions [3].
The diagnosis of infections attributable to the use of
intravascular catheters or devices is the subject of intense
clinical research. There is, however, no consensus on a
true gold standard, and the accuracy of numerous micro-
biological methods has generated vigorous debate among
experts [4]. In addition, the variability in the definitions
used over the past decades has not simplified the under-
standing of the literature [5].
In this context, the distinction between device-associated
and device-related infections proposed in the 2002 guide-
lines for the prevention of intravascular catheter-related
infections provided a useful tool [6]. Infection rates vary
according to the type of surveillance. In studies designed
to study complications associated with the use of intra-
vascular devices, epidemiological definitions frequently
result in higher infection rates. In studies dedicated to
device surveillance, systematic microbiological investi-
gation allows the determination of infection rates directly
related to the colonization or infection of the device [7].
Diagnosis of infections associated with
or related to vascular access
Before reviewing the methods available to diagnose
intravascular catheter-related infections, it is importantorized reproduction of this article is prohibited.
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the literature.
Definitions for vascular access-associated
and related infections
Infections linked to the use of intravascular devices
include exit-site infections, catheter colonization and
both catheter-associated and catheter-related infections
[6,8–15] (Table 1).
Catheter-associated infections include primary blood-
stream infections and clinical sepsis, which are epide-
miologically associated with the use of intravascular
devices [6,7]. It should be emphasized that in the
absence of device culture, defervescence after the
removal of an implicated catheter from a patient withopyright © Lippincott Williams & Wilkins. Unautho
Table 1 Definitions of infections potentially related to vascular acc
Type of infection Criteria
Exit-site infection Clinically documented: a cl
discharge) at the skin
Microbiologically document
of clinical signs of infe
Catheter colonization In the absence of clinical s
on the device accordin
sonication [9], vortexin
cultures.
Positive blood culture Microorganism potentially p
Bloodstream infection Positive blood culture with
Fever (>100.48F; >388C
Chills
Low blood pressure (syst
In the absence of catheter
from a patient with prim
of catheter-associated
Primary bloodstream infection Laboratory-confirmed blood
distal source of infectio
Secondary bloodstream infection Laboratory-confirmed blood
infection
Clinical sepsis Requires one of the followi
Fever (>100.48F; >388C
Low blood pressure (sys
from baseline)
Oliguria (<20 ml/h)
and the presence of all of t
Blood cultures not perfor
No apparent infection at
Physician institutes thera
Catheter-associated bloodstream infection Primary bloodstream infecti
Catheter-related bloodstream infection Laboratory-confirmed blood
with at least one posit
manifestations of infec
bloodstream infection
methods described in
A positive semi-quantitati
A positive quantitative cu
Paired quantitative blood
Differential period of dev
cfu, Colony-forming units.
a Adapted from [6,12,14,15].
b One of the following:
Common skin contaminant (diphtheroids, Bacillus spp., Propionibacterium
two or more blood cultures drawn on separate sets.
Common skin contaminant (diphtheroids, Bacillus spp., Propionibacterium
one or more blood culture from a patient with a vascular access, and the
Positive antigen test on blood and signs and symptoms with positive laboprimary bloodstream infection is considered indirect
evidence of catheter-associated bloodstream infection.
Comparisons between infection rates in different types
of ICUs are more accurate when infections are reported
as incidence densities associated with the use of intra-
vascular devices. According to this method, widely
diffused by the National Nosocomial Infections Surveil-
lance system and using epidemiological definitions,
catheter-associated infections range between 2.3 and
16.8 episodes per 1000 CVC-days [1]. This may over-
estimate the rate of infections related to intravascular
devices, but is probably more representative of daily life.
This method allows the benchmarking of rates of infec-
tion after eventual adjustment for the case mix without
the need for sophisticated laboratory work-up. Although
included in some reports, secondary bacteraemia, whichrized reproduction of this article is prohibited.
essa
inical infection (erythema, tenderness, induration or purulent
insertion site
ed: a positive (semi) quantitative catheter culture in the presence
ction at the insertion site
igns of infection at the insertion site, growth of microorganisms
g to microbiological criteria from quantitative (technique [8],
g technique [10]) or semi-quantitative (roll-plate technique [11])
athogen cultured from one or more blood culturesb
at least one of the following clinical signs or symptoms:
) or hypothermia (<98.68F; <378C)
olic blood pressure 90 mmHg or decrease >40 mmHg from baseline)
culture, defervescence after removal of an implicated catheter
ary bloodstream infection is considered as indirect evidence
bloodstream infection
stream infection or clinical sepsis occurring without documented
n
stream infection occurring in the presence of another documented
ng signs with no other recognized cause:
) or hypothermia (<98.68F; <378C)
tolic blood pressure 90 mmHg or decrease >40 mmHg
he following conditions:
med or no organism detected in blood
another body site
py for sepsis
on or clinical sepsis in the presence of an intravascular device
stream infection in a patient with an intravascular access
ive blood culture obtained from a peripheral vein, with clinical
tion (fever, chills or hypotension) and no apparent source of the
except the vascular access, and with one of the microbiological
Table 2:
ve culture (>15 cfu/catheter segment) with the same organism [11]
lture (>103 cfu/catheter segment) with the same organism [8–10]
cultures with a 5 : 1 ratio device versus peripheral [12]
ice culture versus peripheral blood culture positivity of >2 h [13]
spp., coagulase-negative staphylococci, or micrococci) cultured from
spp., coagulase-negative staphylococci, or micrococci) cultured from
physician institutes appropriate antimicrobial therapy.
ratory results are not related to an infection at another site.
CIntravascular catheter infection Eggimann 355is related to another documented focus of infection,
should not be considered as being catheter related.
Catheter-related infections include colonization of
the device by microorganisms, exit-site infection and
microbiologically confirmed device-related bloodstream
infection. In the absence of a gold standard reference
technique, microbiological criteria are the subject of
intense clinical research, and their clinical relevance is
currently widely discussed among experts [4]. Maki et al.
[16] recently extracted the risk of bloodstream infec-
tions associated with different intravascular devices from
a systematic review of 200 published prospective studies.
Using microbiologically based criteria, they showed that
all types of intravascular devices are at risk of device-
related bloodstream infections. As rates of infections are
likely to be used for benchmarking, they showed that
expressing the risks of device-related bloodstream infec-
tions per 1000 device-days allows for more meaningful
estimates of risk than measuring bloodstream infections
per 100 devices. Peripheral and midline intravenous
catheters are associated with the lowest rates of infection
(0.1%, 0,4% and 0.5, 0.2 per 1000 device-days, respect-
ively). The rates are slightly higher for arterial catheters
used for haemodynamic monitoring (0.8%, 1.7 per 1000
device-days) and peripherally inserted CVCs in hospi-
talized patients (2.4%, 12.1 per 1000 device-days).
According to these data, the rates are higher for non-
impregnated CVCs inserted in critically ill patients
(4.4%, 2.7 per 1000 device-days). The highest rates
are reported for short-term non-cuffed and non-tunneled
haemodialysis catheters (8.0%, 4.8 per 1000 device-
days), for intra-aortic balloon pumps (3.0%, 7.3 per
1000 device-days), and for left ventricular assist devices
(21.6%, 2.1 per 1000 device-days).
Clinical diagnosis of infections associated
with vascular access
Except for some exit-site infections, the clinical diag-
nosis of infections related to vascular access is difficult.
Most clinical signs are insensitive, non-specific or late,
such as septic thrombophlebitis, endocarditis or septic
emboli. Accordingly, they are clinically suspected when
clinical sepsis develops without other obvious sources
of infection.
The concept of ‘clinical sepsis’ is included in the sur-
veillance definitions proposed by the Centers for Disease
Control and Prevention for primary bloodstream infec-
tions to take into account sepsis episodes in which no
pathogen has been cultured from blood [6]. This entity
that is used for epidemiological purposes is relatively
close to the definition of the syndromes of systematic
inflammatory response, severe sepsis and septic shock
in response to an inflammatory or infectious process
[17,18].opyright © Lippincott Williams & Wilkins. UnauthThe definition is sensitive but non-specific. The impact
of clinical sepsis is very close to that of a microbiologically
documented episode. In a prospective surveillance study
of nosocomial infections in 1068 patients who stayed in
a medical ICU for more than 48 h, Hugonnet et al. [7]
analysed 109 episodes of bloodstream infections,
including 32 episodes of microbiologically documented
catheter-related infections and 77 of clinical sepsis.
Exposure to central lines and arterial lines, censored
at the time of the first episode of bloodstream infection,
was similar in patients with a microbiologically docu-
mented episode and those with clinical sepsis, but was
significantly lower in patients without bloodstream
infection. The median ICU length of stay was longer
in patients with microbiologically documented blood-
stream infections (15.5 days; range 4–67) and clinical
sepsis (14.0 days; range 3–48) than among patients with-
out bloodstream infection (4 days; range 2–134; both
P< 0.001). The hospital mortality rates in patients with-
out a bloodstream infection, with a microbiologically
confirmed bloodstream infection, and with clinical sepsis
were 22.7, 32.1, and 39.7%, respectively (P¼ 0.01).
These data strongly suggest that clinical sepsis and
primary bloodstream infection microbiologically related
to intravascular devices have the same impact.
If confirmed by large multicentre clinical trials, these data
may justify the aggressive strategy currently applied at
the bedside in many ICUs, where suspect intravascular
devices are removed or exchanged over a guidewire in
all cases of clinical sepsis associated with severe sepsis or
septic shock developing without another obvious source
of infection. This technique may increase the likelihood
of infection of the new catheter, but reduces the rate of
complications associated with CVC insertion in a new site
[19]. Removal of the exchanged device with further
insertion at a new site is then only required in the
presence of a positive culture of the exchanged device
[20].
Only approximately a quarter to one third of these
episodes will be demonstrated to be caused by a micro-
biologically documented infection of the intravascular
device, and experts suggested that ‘. . . nontunneled
CVCs should not be routinely removed in patients with
mild to moderate disease’ [21,22].
Rijinders et al. [23] studied the impact of a clinical
algorithm designed to avoid catheter removal in ICU
patients developing clinical sepsis. Of 140 patients poten-
tially eligible, 80 (55%) were excluded for haemodynamic
instability, confirmed bacteraemia or local signs of infec-
tion at the insertion site. During the 10 days after
inclusion, only 16 CVCs (38%) were removed in the
‘watchful waiting’ arm (32 patients) compared with 38
(100%) in the control group (32 patients), P< 0.01.orized reproduction of this article is prohibited.
C356 Nosocomial and hospital-related infectionsA catheter-related bloodstream infection developed in
three (1%) compared with two (1%) patients, respect-
ively, but in 47 (25%) of those excluded before random-
ization. This preliminary result confirms that some CVCs
may be maintained, and further studies should now
confirm the usefulness of this approach.
In this context, microbiological techniques likely to pro-
vide early laboratory confirmation of the clinical suspicion
of device-related infection should be improved to avoid
unnecessary intravascular device removal or exchange.
Microbiological diagnosis of infections
related to vascular access
A large majority of primary bloodstream infections
originates from infected vascular access, but a microbio-
logical confirmation of an infection of the device is
required to be scored as an intravascular access-related
bloodstream infection.
Microbiological methods
Many microbiological methods have been described to
diagnose intravascular access-related infections, but in
the absence of a true gold standard there is currently no
consensus of opinion on which method to use. These
methods may be divided schematically into those requir-
ing study of the catheter itself and those that avoid
removing the device. They are the subject of intense
clinical research, and meta-analyses on the performance
of some of these methods have recently appeared in the
literature [8–13,15,21,24–35] (Table 2).
Of particular interest is the fact that paired qualitative
blood cultures drawn from the device and venipunctures
and cultures of swabs obtained from the skin insertion
site or from the hub, which are less sophisticated from a
microbiological point of view but are also cheaper, are
characterized by a high specificity and have the highest
negative predictive value. This may explain partly why
more sophisticated microbiological methods with high
sensitivity and the highest positive predictive value and
accuracy are currently not widely used.
Comparison of methods
Some microbiological techniques have been carefully
compared in a few prospective studies.
In a prospective cohort study on 128 CVCs suspected of
causing catheter-related bloodstream infection, Kite et al.
[30] compared the performance of four methods that
allowed the device to remain in situ. The sensitivity of
the Gram stain and acridine-orange leukocyte cytospin
test was 96% and the specificity was 92%. By comparison,
the tip-roll, tip-flush, and endoluminal-brush methods
had sensitivities of 90, 95, and 92%, respectively, with
specificities of 55, 76, and 98%, respectively. From theseopyright © Lippincott Williams & Wilkins. Unauthodata, the authors concluded that the Gram stain and
acridine-orange leukocyte cytospin test are simple and
rapid methods for the diagnosis of catheter-related
bloodstream infection, which compare favourably with
other methods.
In a prospective cohort study of 125 CVCs suspected of
causing catheter-related bloodstream infection, Catton
et al. [36] compared the performance of three methods
that allowed the device to remain in situ. The sensitivities
of the endoluminal brush, of quantitative culture blood
cultures, and of the differential time to positivity were
100, 89, and 72%, respectively, with corresponding spe-
cificities of 89, 97, and 95%, respectively. Blood could be
directly aspirated from only 74% of all lumens; however,
the authors concluded that the differential time to posi-
tivity was the most simple technique to perform. As a
result of the high specificity of the method, they recom-
mended its use as a first-line approach, with the endo-
luminal brush technique reserved for cases in which
blood cannot be obtained from the device.
In a prospective cohort study of 204 CVCs suspected
of causing catheter-related bloodstream infections in
critically ill patients, Bouza et al. [37] compared the
performance of three methods that allowed the device to
remain in situ. The sensitivity and specificity of cultures
of swabs from the insertion site and from the hub were
78.6 and 92.0%, respectively; for differential quantitative
blood cultures, 71.4 and 97.7%, respectively; and for
the differential time to positivity, 96.4 and 90.3%,
respectively. From these data, the authors argued that
convenience in different medical contexts, the use of
resources, and expertise should determine the choice of a
technique. As a result of the ease of performance, low
cost, and wide availability, they recommended combin-
ing semiquantitative superficial cultures and peripheral
vein blood cultures for the screening of devices sus-
pected of causing infection, and to use differential
quantitative blood cultures as a confirmatory method.
Those studies suggested that the choice of a precise
microbiological method, or of the eventual combinations
of some of them, should be made according to technical
availability and should be integrated in strategies dis-
cussed between clinicians and microbiologists in order to
provide useful information at the bedside. In addition,
economic considerations, such as cost-effectiveness, may
also be taken into account.
Recommendations of experts
Experts have proposed algorithms taking into account
most of these difficulties to help clinicians in the
diagnosis of intravascular access-related infections.
Worthington and Eliott [4] suggested obtaining for every
patient two sets of paired blood cultures drawn throughrized reproduction of this article is prohibited.
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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C358 Nosocomial and hospital-related infectionsthe device and peripherally from venipuncture. A suffi-
cient volume of blood collected per set (20–30 ml) and
inoculated into both aerobic and anaerobic media should
allow the identification of 99% of detectable bacterae-
mias. In cases in which clinical judgement mandates the
removal of the device, quantitative cultures should pro-
vide information likely to confirm the diagnosis. If
the intravascular access is not removed, the differential
time to positivity is then recommended as the first-line
method, followed by quantitative blood cultures. Alter-
natively, if only qualitative blood cultures are available,
the authors strongly recommend performing additional
tests, such as culture of the device, to improve the
sensitivity of the method. In any cases of positive micro-
biological cultures, the authors recommend applying
more strict criteria in the presence of coagulase-negative
staphylococci likely to reflect only contamination [4].
The International Sepsis Forum Consensus Conference
on Definitions of Infection in the Intensive Care Unit
suggested taking into account risk factors likely to
increase the probability of an infection being related to
an intravascular access in its management. Removal of
the device is strongly recommended in the presence of
severe sepsis or septic shock with episodes of hypoten-
sion when the catheter is flushed, with the catheter in
place for more than 7 days or inserted in non-sterile
conditions, or with evidence of exit-site infection. In
the absence of bacteraemia but positive culture of the
tip of the device, the hub or the exit-site, the infection is
scored as a possible clinical catheter-related sepsis. It is
scored as a catheter-related sepsis with bacteriological
confirmation in the presence of bacteraemia with com-
mon skin commensals and positive culture of the tip or
exit site with the same microorganism [18].
Conclusion
The distinction between device-associated and device-
related infections has improved our ability to diagnose
clinical infections at the bedside, and has clarified the
situations in which further microbiological diagnostic
methods should be performed. Despite the usefulness
of the recently proposed algorithms, however, they all
include some simplifications, and none has been vali-
dated in prospective clinical trials. In addition, the poten-
tial impact of concomitant systemic antibiotic treatment
or the use of antiseptic/antimicrobial-coated devices on
the accuracy of microbiological techniques remains to
be determined.
Accordingly, precise diagnostic criteria should be clearly
discussed and defined in each institution by a close
collaboration between clinicians and microbiologists.
They should then be used for eventual benchmarking
and further integrated into global strategies targeted atopyright © Lippincott Williams & Wilkins. Unauthothe prevention of vascular access-related or associated
infections.
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